Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28
Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. MD | 0.00 |
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:
MD) with a Hold and raises the price target from $23 to $28.
